Literature DB >> 26619137

Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants.

Sharath P Sasi, Sanggyu Bae, Jin Song, Aleksandr Perepletchikov, Douglas Schneider, Joseph Carrozza, Xinhua Yan, Raj Kishore, Heiko Enderling, David A Goukassian.   

Abstract

Entities:  

Year:  2015        PMID： 26619137      PMCID： PMC4664239          DOI： 10.1371/journal.pone.0144213

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
In the Funding section, the grant number NNJ10ZSA001N from the funder National Aeronautic and Space Administration has been updated by the funder. The updated grant number is: NNX11AD22G.
  1 in total

1.  Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants.

Authors:  Sharath P Sasi; Sanggyu Bae; Jin Song; Aleksandr Perepletchikov; Douglas Schneider; Joseph Carrozza; Xinhua Yan; Raj Kishore; Heiko Enderling; David A Goukassian
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240
  1 in total
  1 in total

Review 1.  Unleashing endogenous TNF-alpha as a cancer immunotherapeutic.

Authors:  Steven F Josephs; Thomas E Ichim; Stephen M Prince; Santosh Kesari; Francesco M Marincola; Anton Rolando Escobedo; Amir Jafri
Journal:  J Transl Med       Date:  2018-08-31       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.